CDKN2A Gene Melanoma and Neural System Tumor Syndrome Familial NGS Genetic DNA Test
Introduction
The CDKN2A Gene Melanoma and Neural System Tumor Syndrome Familial NGS Genetic DNA Test is a cutting-edge genetic test designed to identify mutations in the CDKN2A gene, which are associated with an increased risk of melanoma and neural system tumors. This test is crucial for individuals with a family history of these cancers, as it provides valuable insights into their genetic predisposition and informs preventive measures.
What the Test Measures
This genetic test specifically detects mutations in the CDKN2A gene, which plays a significant role in regulating the cell cycle. By analyzing the DNA, the test can identify whether an individual carries a mutation that may increase their risk of developing melanoma or other neural system tumors.
Who Should Consider This Test?
Individuals with a family history of melanoma or neural system tumors should consider this test, especially if they exhibit any of the following risk factors:
- Multiple family members diagnosed with melanoma.
- Early onset of melanoma in family members.
- Personal history of skin cancer or atypical moles.
Benefits of Taking the Test
Taking the CDKN2A Gene Melanoma and Neural System Tumor Syndrome Familial NGS Genetic DNA Test offers several benefits:
- Early Detection: Identifies individuals at high risk, allowing for proactive monitoring and preventive measures.
- Informed Decisions: Helps patients and their families make informed choices regarding lifestyle and screening.
- Targeted Management: Provides oncologists with essential information to tailor treatment plans for affected individuals.
Understanding Your Results
Results from the test will indicate whether a mutation in the CDKN2A gene is present. A positive result suggests an increased risk of melanoma and neural system tumors, while a negative result indicates no detectable mutation. It is crucial to discuss the results with a healthcare provider who can guide you on the next steps.
Test Pricing
| Test Name | Discount Price (KSh) | Regular Price (KSh) |
|---|---|---|
| CDKN2A Gene Melanoma and Neural System Tumor Syndrome Familial NGS Genetic DNA Test | 40,000 | 56,000 |
Book Your Test Today!
We have branches across Kenya, including major cities like Nairobi, Mombasa, and Kisumu. You can also opt for our home sample collection service for your convenience. To book the CDKN2A Gene Melanoma and Neural System Tumor Syndrome Familial NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.
Don’t wait for symptoms to appear; take charge of your health today!
